Authors:
MILLER JD
HUSE DM
RUSSELL MW
SAROCCO P
HARTZ SC
Citation: Jd. Miller et al., ECONOMIC SEGMENTATION OF STATINS - PRICE VERSUS EFFICIENCY, Journal of the American College of Cardiology, 31(2), 1998, pp. 486-486
Authors:
RUSSELL MW
HUSE DM
DROWNS S
HAMEL EC
HARTZ SC
Citation: Mw. Russell et al., DIRECT MEDICAL COSTS OF CORONARY-ARTERY DISEASE IN THE UNITED-STATES, The American journal of cardiology, 81(9), 1998, pp. 1110-1115
Authors:
HUSE DM
RUSSELL MW
MILLER JD
KRAEMER DF
HARTZ SC
Citation: Dm. Huse et al., COST-EFFECTIVENESS OF HMG-COA REDUCTASE INHIBITION IN PRIMARY PREVENTION OF CHD - NEW EVIDENCE COMPARING ALL AVAILABLE AGENTS, American journal of managed care, 3(10), 1997, pp. 21-21
Citation: Mw. Russell et al., A FLEXIBLE COMPUTER-BASED MODEL FOR ESTIMATING DIRECT MEDICAL COSTS OF CORONARY-ARTERY DISEASE (CAD), American journal of managed care, 3(10), 1997, pp. 22-22
Citation: Dm. Huse et al., ECONOMIC-EVALUATION OF FAMCICLOVIR IN REDUCING THE DURATION OF POSTHERPETIC NEURALGIA, American journal of health-system pharmacy, 54(10), 1997, pp. 1180-1184
Authors:
SYTKOWSKI PA
DAGOSTINO RB
HUSE DM
SILBERSHATZ H
LEVY D
HARTZ SC
Citation: Pa. Sytkowski et al., APPRAISING RISK OF CARDIOVASCULAR-DISEASE AMONG TREATED HYPERTENSIVES, Journal of the American College of Cardiology, 29(2), 1997, pp. 10547-10547
Authors:
KLAUS DH
HUSE DM
WEISS ST
RICHNER RE
KURIYAMA N
HARTZ SC
Citation: Dh. Klaus et al., THE PREVALENCE OF SINUSITIS AND NASAL POLYPS AMONG PATIENTS WITH ASTHMA IN THE ASTHMA OUTCOMES REGISTRY, Journal of allergy and clinical immunology, 99(1), 1997, pp. 555-555
Authors:
SYTKOWSKI PA
DAGOSTINO RB
HUSE DM
RUSSELL MW
HARTZ SC
Citation: Pa. Sytkowski et al., NEW CORONARY RISK FUNCTIONS FOR PHARMACOLOGICALLY TREATED HYPERTENSIVES - THE FRAMINGHAM HEART-STUDY, Circulation, 96(8), 1997, pp. 2444-2444
Authors:
OSTER G
DELEA TE
HUSE DM
REGAN MM
COLDITZ GA
Citation: G. Oster et al., THE BENEFITS AND RISKS OF OVER-THE-COUNTER AVAILABILITY OF NICOTINE POLACRILEX (NICOTINE GUM), Medical care, 34(5), 1996, pp. 389-402
Authors:
OSTER G
HUSE DM
LACEY MJ
REGAN MM
FUCHS HJ
Citation: G. Oster et al., EFFECTS OF RECOMBINANT HUMAN DNASE THERAPY ON HEALTH-CARE USE AND COSTS IN PATIENTS WITH CYSTIC-FIBROSIS, The Annals of pharmacotherapy, 29(5), 1995, pp. 459-464
Citation: Dm. Huse et al., CHILDHOOD VACCINATION AGAINST CHICKENPOX - AN ANALYSIS OF BENEFITS AND COSTS, The Journal of pediatrics, 124(6), 1994, pp. 869-874
Authors:
CETTA F
DRISCOLL DJ
LUCAS AR
UREVIG RL
HUSE DM
ECKERT SK
WEIDMAN WH
Citation: F. Cetta et al., GROWTH-PATTERNS OF HYPERLIPIDEMIC CHILDREN ENROLLED IN A PREVENTIVE CARDIOVASCULAR HEALTH CLINIC, Clinical pediatrics, 33(10), 1994, pp. 588-592
Citation: D. Thompson et al., CEFAZOLIN VERSUS CEFTRIAXONE IN LOWER RESPIRATORY-TRACT INFECTION - REPLY, The Annals of pharmacotherapy, 27(5), 1993, pp. 654-654
Authors:
CETTA F
DRISCOLL DJ
LUCAS AR
HUSE DM
ECKERT SK
WEIDMAN WH
Citation: F. Cetta et al., GROWTH-PATTERNS OF HYPERLIPIDEMIC CHILDREN EATING A FAT AND CHOLESTEROL CONTROLLED DIET, Clinical research, 41(3), 1993, pp. 10000695-10000695